Baxter - 37 Year Stock Split History | BAX

Stock split history for Baxter since 1981. Prices shown are actual historical values and are not adjusted for either splits or dividends. Please see the "Historical Prices" tab for adjusted price values.
Baxter Annual Stock Splits
Baxter Quarterly Stock Splits
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $35.653B $10.561B
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide. Baxter India is a wholly owned subsidiary of Baxter International Inc. Baxter India believes in engaging collaboratively with patients, healthcare providers, governments and non - government organizations to help change the lives of millions of people by providing safe, effective and affordable products and therapies.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $128.543B 19.22
Abbott Laboratories (ABT) United States $127.387B 25.81
Stryker (SYK) United States $64.588B 24.35
Boston Scientific (BSX) United States $51.339B 25.94
Zimmer Biomet Holdings (ZBH) United States $23.039B 14.94
Smith & Nephew SNATS (SNN) United Kingdom $16.882B 0.00
ResMed (RMD) United States $16.410B 31.29
Perrigo (PRGO) Ireland $7.997B 12.14
Bio-Rad Laboratories (BIO) United States $7.618B 48.71
Canopy Growth (CGC) Canada $7.436B 0.00
Hill-Rom Holdings (HRC) United States $6.496B 20.32
Aurora Cannabis (ACB) Canada $6.099B 32.21
Haemonetics (HAE) United States $5.365B 47.18
Insulet (PODD) United States $4.925B 0.00
ICU Medical (ICUI) United States $4.805B 26.77
Hutchison China MediTech (HCM) China $4.419B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.779B 0.00
Neogen (NEOG) United States $3.367B 50.98
Agios Pharmaceuticals (AGIO) United States $3.261B 0.00
NuVasive (NUVA) United States $2.912B 27.09
National Vision Holdings (EYE) United States $2.458B 47.55
Quidel (QDEL) United States $2.024B 26.39
NxStage Medical (NXTM) United States $1.918B 0.00
Aphria (APHA) $1.451B 0.00
Phibro Animal Health (PAHC) United States $1.321B 18.70
AtriCure (ATRC) United States $1.188B 0.00
Cardiovascular Systems (CSII) United States $1.021B 1469.50
VAREX IMAGING (VREX) United States $0.937B 18.76
PetIQ (PETQ) United States $0.858B 22.23
Surmodics (SRDX) United States $0.786B 119.80
Cerus (CERS) United States $0.780B 0.00
Meridian Bioscience (VIVO) United States $0.778B 24.78
OraSure Technologies (OSUR) United States $0.747B 42.07
Omeros (OMER) United States $0.703B 0.00
Lantheus Holdings (LNTH) United States $0.670B 20.75
Eagle Pharmaceuticals (EGRX) United States $0.661B 21.21
MacroGenics (MGNX) United States $0.605B 0.00
NanoString Technologies (NSTG) United States $0.536B 0.00
LeMaitre Vascular (LMAT) United States $0.514B 25.24
Quanterix (QTRX) United States $0.438B 0.00
Owens & Minor (OMI) United States $0.428B 4.84
TG Therapeutics (TGTX) United States $0.423B 0.00
Insys Therapeutics (INSY) United States $0.376B 0.00
Utah Medical Products (UTMD) United States $0.331B 21.40
Evolus (EOLS) United States $0.327B 0.00
VAPOTHERM INC (VAPO) United States $0.307B 0.00
Cytosorbents (CTSO) United States $0.282B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.241B 0.00
Surface Oncology (SURF) United States $0.238B 0.00
Bovie Medical (BVX) United States $0.236B 0.00
BioLife Solutions (BLFS) United States $0.222B 300.25
Rockwell Medical (RMTI) United States $0.182B 0.00
Chimerix (CMRX) United States $0.172B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.142B 0.00
Fonar (FONR) United States $0.136B 6.83
Chembio Diagnostics (CEMI) United States $0.106B 0.00
United-Guardian (UG) United States $0.080B 16.81
Female Health (VERU) United States $0.079B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.070B 0.00
InfuSystems Holdings (INFU) United States $0.068B 0.00
Trinity Biotech (TRIB) Ireland $0.065B 17.93
CAS Medical Systems (CASM) United States $0.053B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Neurotrope (NTRP) United States $0.030B 0.00
Myomo (MYO) United States $0.023B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.019B 0.00
Capricor Therapeutics (CAPR) United States $0.017B 0.00
Akers Biosciences Inc (AKER) United States $0.016B 0.00
Senestech (SNES) United States $0.015B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00